Effect of Adherence to HAART on Virologic Outcome and on the Selection of Resistance-Conferring Mutations in NNRTI- or PI-Treated Patients

Abstract

Low adherence is a major determinant of virologic failure, however different therapies have different adherence cutoffs determining a significant increment of risk.